You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CALCIUM GLUCONATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Calcium Gluconate, and when can generic versions of Calcium Gluconate launch?

Calcium Gluconate is a drug marketed by Amneal, B Braun Medical Inc, Fresenius Kabi Usa, Nivagen Pharms Inc, Somerset, and Hq Spclt Pharma. and is included in seven NDAs. There are two patents protecting this drug.

The generic ingredient in CALCIUM GLUCONATE is calcium gluconate. There are two hundred and eighty-two drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the calcium gluconate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Calcium Gluconate

A generic version of CALCIUM GLUCONATE was approved as calcium gluconate by FRESENIUS KABI USA on June 15th, 2017.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CALCIUM GLUCONATE?
  • What are the global sales for CALCIUM GLUCONATE?
  • What is Average Wholesale Price for CALCIUM GLUCONATE?
Drug patent expirations by year for CALCIUM GLUCONATE
Drug Prices for CALCIUM GLUCONATE

See drug prices for CALCIUM GLUCONATE

Recent Clinical Trials for CALCIUM GLUCONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ascension Genesys HospitalPhase 2
Aurora Health CarePhase 4
First Affiliated Hospital Xi'an Jiaotong UniversityN/A

See all CALCIUM GLUCONATE clinical trials

Pharmacology for CALCIUM GLUCONATE

US Patents and Regulatory Information for CALCIUM GLUCONATE

CALCIUM GLUCONATE is protected by zero US patents and two FDA Regulatory Exclusivities.

FDA Regulatory Exclusivity protecting CALCIUM GLUCONATE

COMPETITIVE GENERIC THERAPY
Exclusivity Expiration: ⤷  Sign Up

COMPETITIVE GENERIC THERAPY
Exclusivity Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal CALCIUM GLUCONATE calcium gluconate SOLUTION;INTRAVENOUS 216611-001 May 10, 2024 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hq Spclt Pharma CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 210906-001 Oct 29, 2018 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Fresenius Kabi Usa CALCIUM GLUCONATE calcium gluconate SOLUTION;INTRAVENOUS 208418-003 Jun 15, 2017 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
B Braun Medical Inc CALCIUM GLUCONATE calcium gluconate SOLUTION;INTRAVENOUS 216541-001 Aug 21, 2023 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.